- Published at
- by investing.com
neutral
neutral
Scilex Holding's executive chairperson buys $44k in company stock By Investing.com
Scilex Holding's executive chairperson buys $44k in company stock
News for Vickers Vantage Corp. I (VCKAU)
- Published at
- by globenewswire.com
mixedmixedSorrento Issues “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a “Frequently Asked Questions” document...- Published at
- by globenewswire.com
mixedmixedScilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
PALO ALTO, Calif., Jan. 29, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento...- Published at
- by seekingalpha.com
mixedmixedA SPAC, Spinoff, And Short Squeeze Walk Into A Bar (NASDAQ:SCLX)
Shares of Scilex could trade higher due to hedging pressure from large Sorrento short positions. Read about the unique market situation involving SCLX and SRNE.- Published at
- by seekingalpha.com
positivepositiveRed Flags Waving As Scilex' Surprisingly High Valuation Starts To Correct (NASDAQ:SCLX)
Scilex was formed via a SPAC merger. Read why Scilex stock is falling and why the latest correction may continue.- Published at
- by seekingalpha.com
mixedmixedShares of newly public biotech Scilex climb 5% following SPAC merger (NASDAQ:SCLX)
Newly public Scilex (SCLX) stock rose 5% in afternoon trading following the biotech company's merger with SPAC Vickers Vantage Corp I.- Published at
- by benzinga.com
mixedmixedScilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), Debuts on Nasdaq Under Ticker "SCLX" - Sorrento Therapeutics (NASDAQ:SRNE)
Scilex plans to accelerate growth as a public company and advance further its non-opioid pain management therapeutic portfolio to transform the acute and chronic pain outpatient marketScilex will ring the Nasdaq opening- Published at
- by globenewswire.com
mixedmixedScilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), Debuts on Nasdaq Under Ticker “SCLX”
Scilex Holding Company to Ring the Nasdaq Opening Bell on Friday, November 11, 2022 at 9:30 a.m. ET...- Published at
- by globenewswire.com
neutralneutralScilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business C
Approximately 80% of the shareholders of Vickers present at the meeting of Vickers shareholders in connection with the business combination voted in favor...- Published at
- by seekingalpha.com
negativenegativeSorrento: Limited Potential, High Management Compensation, Complicated Lawsuits (SRNE)
Sorrento Therapeutics has been in the limelight for all the wrong reasons. Its R&D is just a byproduct of its business. Read what investors need to know.- Published at
- by globenewswire.com
mixedmixedScilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors
PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of...- Published at
- by gurufocus.com
positivepositiveSeaport Global Asset Management Llc Buys Enovix Corp, AFC Gamma Inc, Chicken Soup for the Soul Entertainment Inc, Sells Yunji Inc, Lithium Americas Corp, Coliseum Acquisition Corp
GuruFocus Article or News written by insider and the topic is about: